Telmikind-AM Tablet is unsafe to use during pregnancy.There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

Telmikind-AM Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.

Do not drive unless you are feeling well.Telmikind-AM Tablet may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.

Telmikind-AM Tablet is safe to use in patients with kidney disease. No dose adjustment of Telmikind-AM Tablet is recommended.

Telmikind-AM Tablet should be used with caution in patients with liver disease. Dose adjustment of Telmikind-AM Tablet may be needed. Please consult your doctor.Telmikind-AM Tablet is started at a lower dose in patients with liver disease and further increased slowly with careful monitoring.